University of Connecticut

OpenCommons@UConn
Honors Scholar Theses

Honors Scholar Program

Spring 5-1-2015

Manipulation of the Microbiome and Its Impact on
Functional Recovery Following Ischemic Stroke
Michal Jandzinski
michal.jandzinski@uconn.edu

Follow this and additional works at: https://opencommons.uconn.edu/srhonors_theses
Part of the Biochemical Phenomena, Metabolism, and Nutrition Commons, Biology Commons,
Medical Microbiology Commons, Neurosciences Commons, Other Cell and Developmental
Biology Commons, Other Immunology and Infectious Disease Commons, and the Systems and
Integrative Physiology Commons
Recommended Citation
Jandzinski, Michal, "Manipulation of the Microbiome and Its Impact on Functional Recovery Following Ischemic Stroke" (2015).
Honors Scholar Theses. 414.
https://opencommons.uconn.edu/srhonors_theses/414

Manipulation of the Microbiome and Its Impact on Functional Recovery Following Ischemic
Stroke

Michal Jandzinski
University of Connecticut, 2015

We are all covered from head to toe, internally and externally, by trillions of microbes without
even realizing it. Who are these microscopic neighbors of ours? How did they come to inhabit
every square inch of our bodies? What purpose do they serve? These are all questions that this
paper will seek to explore and answer in the background section. Following the discussion, the
background knowledge will be applied to a completely novel area of research: how the
microbiome impacts ischemic stroke.
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Background
Trends exist all over the world in all sorts of things. As of late, modern scientific literature has
recently been seduced and infatuated with the microbiome, the bacteria that live inside all
organisms. As this paper will demonstrate, though, this microbial fascination isn’t without good
reason. The aim of this background section is to give a thorough overview on the basic ideas
behind the microbiome: what is it? Where does it come from? What does it do? And what does it
do in diseases? At the end there will be a brief discussion on the “frontier” of microbiome
research, so to speak, which is a growing body of evidence pertaining to the microbiome’s
influence on the brain. At the end of this section it will hopefully become clear why the
microbiome is a legitimate area of concern for all concerned with health and wellness and why
the microbiome should not be ignored as a potential source of insight and treatment opportunities
as it pertains to the various diseases that humans are faced with today.
So what’s the big deal?
For every single human cell in the body, there are roughly 10 microbial cells[1]. These microbes
inhabit nearly all parts of the body, residing all over the skin, throughout the entire
gastrointestinal tract, in the oral and nasal cavities, and just about everywhere else. In many ways
it would be naive to argue that this microbiome, “the collective genomes and gene products of
resident microbes living inside and on humans”, has no impact on a person’s development and
overall health[1]. In modern scientific literature, there has been a massive wave of research
showing the fundamental contributions of the microbiome to organisms’ daily maintenance of
homeostasis and development of diseased states. These microbial communities commonly form
commensal relationships with hosts, carrying out functions that are vital to host survival such as
food digestion, prevention of pathogen proliferation, and even assist proper development of the
innate immune system[1][8]. In other instances, specific groups of microbes or deregulation of
normal microbiome populations can cause homeostatic dysfunction or disease[1-3][8-14].
Even though these microbes can have a wide range of impacts on health and even though there is
a wide range of them, it has been found that all these microbes can actually be sorted into a very
limited number of groups. More specifically only four main bacterial phyla, groups consisting of
hundreds of bacterial genera and species, really constitute human microbiome populations:
Actinobacteria, Bacteroidetes, Firmicutes, and Proteobacteria[15] (Table 1). Despite the
dominance by four bacterial phyla, there is still an impressive level of diversity in the relative
microbial compositions at different body locations[1][16]. Human skin, for example, contains

2

nearly insignificant relative abundances of Bacteroidetes relative to other body locations.
Gastrointestinal tract studies have shown that, in both children and adults, the microbiome
populations can be broken down to basically 2 groups; mainly composed of Bacteroidetes and
Firmicutes, with the two phyla accounting for roughly 98% of 16s RNA sequences detected in
the gut of mammals[1-3][17][19]. The 16s RNA (rRNA) gene is used as a small genetic marker
(about 1.5kb in size) that has been highly conserved amongst bacterial species and phyla to allow
for species to be distinguished from one another along with being able to classify groups of
microbes from the same or different phyla[30].
Phylum

Main Classes

Commonly examples

General traits of microbes

Actinobacteria

Actinobacteria

Bifdobacterium, Streptomyces,
Nocardia

Gram-positive with high content of G+C in DNA.
Diverse morphologies, physiological/metabolic
properties. Phyla includes pathogens(ie.
Nocardia), GI commensals (ie.Bifdobacterium),
and even microbes adapted to living in soils (ie.
Streptomyces)[1][18]

Bacteroidetes

Bacteroidetes

Bacteroides, Prevotella,
Flavobacteria

Gram-negative with 4 broad classes with microbes
adapted to live in soils, seawater, and guts of
animals. Display varied morphologies and range
from strict aerobes to strict anaerobes. Often
regarded as specialists of degradation of large
organic substrates such as proteins and
carbohydrates[1][9]

Firmicutes

Bacilli, Clostridia

Clostridium, Staphylococcus,
Enterococcus

Gram-positive with cocci or bacillus
morphologies. Typically display low G+C content
in DNA. Play roles in energy resorption in the gut
an have been implicated in many diseased states
including obesity[1].

Proteobacteria

Gammaproteobacteria,
Betaproteobacteria

Escherichia, Pseudomonas,
Helicobacter

Gram-negative bacteria that are typically
pathogenic in nature[20].

Table 1: The four predominant bacterial phyla that compose the human microbiome.

Out of all of the bodily locations that host the commensals, the gastrointestinal tract has proven
to be the most significant to human health. By most estimates, the GI tract is the clear favorite
area of residence for our microbial neighbors, hosting over 70% of the microorganisms in the
body[28]. While that may seem like an shocking amount, it makes sense; if a person took their
own gut and flattened out all the villi and microvilli the structure would have a surface area of
about 32 square meters, the floor size of a small studio apartment or about half a badminton
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court[29]. But the GI tract doesn’t just offer the commensals a lot of real estate, it offers them lots
of real estate that’s full of nutrients and minerals that they can use to grow, survive, and
proliferate, making it the clear choice for microbes that are deciding what portion of the human
body to colonize. After establishing their community in a person’s body, this overwhelming
majority that resides in the gut plays an incredibly important role in a person’s health. All the
previously mentioned impacts of the microbiome stem directly from this gut community in one
way or another.
Starting from day 1
This begs the question of where do these microorganisms come from? Are people born with
them? Or do they infect hosts after birth? As it turns out, the bacteria that are found inside every
person’s gut are mainly descendants from an initial wave of microbes that colonize sterile
newborns in the immediate moments following birth[1]. During the seconds following birth,
hundreds, thousands, and even millions of microbe begin attempting to colonize newborn’s
body. Studies comparing the microbiome compositions of vaginal and cesarean delivered
newborns have shown dramatic differences between the two groups microbial populations,
suggesting that a person’s mode of birth delivery can play a dramatic role in determining the
constituents of their microbiomes. As Figure 1 from Dominguez-Bello(2010) shows,
microbiomes of vaginally delivered newborns were strikingly representative of the maternal
vaginal and intestinal microbial populations while cesarean delivered newborns displayed
microbiome compositions similar to those of their mothers’ skin[11]. Other studies have also
shown a markedly reduced proportion of Bifdobacterium and Bacteroidetes (“good” bacteria) in
the gastrointestinal tracts of cesarean delivered newborns when compared to vaginally delivered
newborns[9]. Regardless of mode of delivery, though, this initial microbial population that
colonizes newborns has been found to distribute itself uniformly throughout the body of the
infant, meaning that the mode of delivery of an individual will lay the foundation of all the
body’s future microbial communities[11, 12].
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Figure 1: 16s bacterial RNA UniFrac analysis
conducted by Dominguez-Bello(2010). Unifrac
analysis uses phylogenetic information to calculate
and display the genomic differences amongst
microbial communities[21]. Significant differences can
be seen in newborns’ microbiome compositions
depending on the baby’s mode of delivery at birth[11].

So what happens after birth and the initial invasion of microbes? After an individual’s
microbiome begins forming after birth, the individual’s environment and lifestyle for the rest of
their life will shape the development of the microbiome. An example of a person’s
environmental factor that will play a role in microbiome development is the type of food that an
infant will first be exposed to. Many mothers are presented with the decision of whether their
children will be breast-fed or formula-fed, but what many are unaware of while making the
decision is that their choice will determine how their child’s microbiome will develop from the
moment they feed them for the first time. Recent developments have led to the general belief in
populations that being breast-fed is generally healthier for children, but not many are actually
aware of what specific impact breast milk has on the health of a child. For starters, breast milk
provides infants with a booster-pack of protective and beneficial goods like cytokines, growth
factors, immunoglobulin’s, lactotransferrin, lysozymes, and human milk oligosaccharides
(HMO’s)[13, 14]. While all the components assist in proper immune development in the infant,
HMO’s play a particularly important role in protecting infants from disease and infection by
acting as decoys for invading pathogens thereby preventing the infectious microbes from gaining
access to epithelial cells[23]. What has been most surprising, however, has been the finding that
shows that the carbohydrate-rich component essentially functions as a prebiotic in the
microbiome by stimulating and promoting the colonization and growth by Bifdobacterium sp[23].
As such, multiple studies have shown that breast-fed infant actually present with much higher
relative abundances of both Bifdobacterium and Lactobacillus (commonly considered beneficial
bacteria) microbes in their gut microbiomes compared to formula-fed infants, who actually show
a significantly increased rate of colonization by Clostridium and other pathogenic microbes
(especially C dificile) which is probably attributed to the lack of protective HMO’s in their
diets[23-25]. Not surprisingly, infants with proportions of beneficial microbes in their microbiomes
have been shown to be better protected from allergies, diarrhea, necrotizing enterocolitis,
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obesity, and even type II diabetes. It’s truly amazing to think how such a seemingly small
decision about a baby’s first food can have such a significant impact on the development of their
microbiome. What’s more impressive, though, is how big of an impact the resulting microbiome
can have on the baby’s development and health later on.
But do environmental factors have a significant impact on the microbiome only during the initial
stages of a person’s life while the microbiome is in it’s early immature stages of development?
Are microbial populations less affected later on in life as their diversity and population size
increases? As it turns out, the microbiome’s sensitivity is not lost with age. In fact, the microbial
composition can be, and is, constantly affected by various environmental factors such as a
person’s diet. In 2006, Turnbaugh was able to rapidly and significantly alter the microbial
compositions in mice containing human microbiomes[26]. David(2013) showed that even shortterm dietary changes can trigger dramatic compositional changes in the human microbiome by
tracking microbial response when subjects shifted to entirely plant-based or animal-based diet.
David(2013) showed animal-based diets significantly increased bile-tolerant microorganisms
while decreasing the abundances of bacteria responsible for metabolizing plant polysaccharides
(the opposite held true for microbiomes introduced to plant-based diets)[26]. The changes that the
microbiomes experience in response to dietary changes don’t simply regress overtime, in fact,
after initial changes occur in the microbiome, the microbiomes stabilize in their new states and
remain stable indefinitely until a new environmental factor is introduced and they must change
again[27].
While only a handful were mentioned here, there are a plethora of environmental and lifestyle
factors that can influence the development and composition of the microbiome. However, it was
previously mentioned that when it comes to the gut, roughly 98% of resident microbes fall into
just two main phyla of bacteria regardless of environmental changes. How can that be? Well, as
it turns out, it’s not a mere coincidence that the invading microbes were allowed to colonize and
reside in the gut after birth, as the following sections will shed light on, host-microbiome
interactions play critical roles in shaping how the immune system will develop and react to
pathogens, in prevention of the propagation of these invading microbes, and carry out processes
so vital to human digestion and metabolism that without them malnutrition would be
unavoidable.
With Great Microbes Comes Great Immunity
Instead of triggering an outburst of protective measures by the immune system, the microbial
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residents of the gut are a critical step in proper development to the system that will ultimately
determine the overall health of the host. The role of the microbiome in the development of the
systemic immune system is most readily seen in studies that have focused on germ-free (GF)
animals that lack any form of colonizing bacteria. These mice that lack the normal endogenous
microbes have been found to contain hypoplastic Peyer's patches, the organized lymphoid
nodules responsible for intestinal immune surveillance and generation of the intestinal immune
response[30]. The spleens and other lymph node structures in the GF mice have also been found to
be defectively formed or entirely functionally absent in mice lacking a proper microbiome[30]. If
the structures that are responsible for the immune response are defective then what about their
products and immune cells? As it turns out, those too are harmed by the lack of a microbiome
with GF mice presenting with inadequate levels of immune cells and their products, such as IgAproducing plasma cells and their immunoglobulins and major irregularities in circulating
cytokine levels and profiles[31-33].
Is it really the microbiome, or lack thereof, responsible for the immunodeficiency that occurs in
the GF animals or is it a mere coincidence? This is the same question that was asked by
researchers when the initial results were reported about the GF mice and to the dismay of many
skeptics of the significance of the microbiome, specific microbial populations were found to play
very specific roles in the modulation of immune development. Along with the previously
mentioned deficiencies that have been reported in GF mice that lack the proper endogenous
microbiome, the mice are also completely devoid of proper CD4+ T cell expansion[34]. These T
cells, are mature T helper cells that are absolutely necessary for a host's immune response to
invading pathogens[35]. Without any intervention, the GF mice would exhibit this deficiency their
entire lives. This deficient phenotype was able to be entirely reversed through the administration
of "good" microbes to the mice from the Bacteroidetes phyla, more specifically Bacteroides
fragilis[34]. More strikingly, it was found that the phenotype was reversed by specific interactions
between the administered microbes and the immune system: dendritic cells recognized specific
epitopes present on the Bacteroidetes phyla, presented the antigens to immature T lymphocytes
in the mesenteric lymph nodes (a required step to T cell activation and expansion), and this
presentation ultimately caused the development and proliferation of CD4+ T cells along with the
lymphocyte-containing compartments in the spleen[34]. The exposure and presence of just one
specific group of microbes not only supports proper immune development, but is actually vital to
the immune system's maturation at both a cellular and organ level.
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Many would still attempt to argue that perhaps the immune system development can be triggered
by any form of microbes, and there is no actual causal relationship between the microbes that are
reported as "good" versus those that are considered harmful. A study comparing GF mice
colonized by altered Schaedler flora (ASF) and GF mice colonized by microbial populations
consisting of mainly Bacteroidetes phyla members showed just how important specific microbial
populations and proportions are for proper immune development. ASF is a bacterial mix
containing 8 bacterial species that are considered the "normal" or archetypal microbial species
that are expected to be present in mice[36]. The mix often contains relatively equal portions of
each group and is commonly used in studies involving the GI tract since it gives researchers an
easily controllable and reproducible microbiome population in their studies. The mix of microbes
in the microbiomes of ASF colonized mice, however, isn’t representative of the endogenous
microbiomes of normal organisms. If the immune system required merely the exposure to
microbes to trigger proper development as many microbiome skeptics would believe, then the
ASF contains more than enough of a variety and number of microbes to trigger some sort of
response. What was actually seen, however, was that ASF colonization wasn't sufficient to
promote differentiation of Th17 cells, T cells necessary for immune functions such as
recruitment, activation, and migration of neutrophils, interleukin-21/22 secretion, and antimicrobial immunity at various epithelial barriers[37]. The GF mice colonized by microbial mixes
found in normal endogenous microbiomes, more importantly, mixes containing high proportions
of Bacteroidetes microbes, normal differentiation and proliferation of Th17 cells was seen[38].
The findings point out the importance of the specific endogenous mixes of microbes that
commonly reside in the endogenous microbiome. The immune system has clear requirements for
exposure to specific antigens provided by the specific microbes present in the microbiome.
Without the proper microbial compositions, the necessary and complex interactions between
host-microbes cannot occur and the normal development of the immune system will be severely
hindered.
The Great Wall of Bacteria
The most obvious yet commonly overlooked benefit that the commensals confer to hosts is the
physical barrier that they provide against antigens from the external environment at the intestinal
mucosa. The most intuitive way that the endogenous microbes do this is by physically excluding
foreign invaders. While the exact mechanisms of action have yet to be elucidated, there is a clear
exclusion of pathogens that occurs when normal microbes colonize the GI tract. Corr(2007) was
able to show that many bacterial strains that are commonly used in probiotic blends such as
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Bifdobacterium and Lactobacillus physically prevent the attachment and invasion of the
pathogenic Listeria through the elaboration of their processes and secretion of compounds that
induced epithelial cell immune/structural responses such as in recent reports that have described
increased expression of tight junction proteins responsible for maintaining the integrity of
multiple vital endothelial barriers like the blood-brain barrier following normal host-microbiome
interactions that occur during development[39, 82]. Lactobacillus has even been shown to decrease
the ability of pathogens E. coli and S. enteritidis to bind their attachment sites on the ileal
mucosa[39- 41].
But the bacterial residents don't simply buy out all the real estate in the gut to keep pathogens
out; they're armed with weapons and are more than willing to use them to keep out unwanted
guests. Microbes from the Lactobacillus genus are an example of of microbes that take it upon
themselves to produce substances to directly prevent pathogenic colonization. So what do they
do? The genus members all produce lactic acid, which creates low pH environments that greatly
deter the growth of bacteria that are not adapted to surviving in the acidic environments[30]. Many
other strains of bacteria normally present in the endogenous microbiome also produce substances
that function to prevent pathogen invasion, such as the Rumminocus gnavus bacteria that produce
lantibiotics (peptide antibiotics produced by many Gram-positive bacteria to attack other Grampositive invaders)[42][43]. Many of the anti-microbial substances released by endogenous
microbiome members often either target other bacteria that are similar to themselves, a simple
yet effective mechanism to eliminate any potential competition for niches from invading
pathogens. Other times the production or activation of the products depends on host mechanisms
like enzymes which further demonstrates the incredible level of co-adaptation of the microbiome
to the host[30][53].
Many of the microbes also help bolster host protective measures by carrying out important steps
to induce expression of antimicrobial substances by the host or to activate anti-microbial
precursors that the host secretes. One incredible example of this is the induction of defensin
expression in the GI tract. Defensins are one type of of anti-microbial peptides produced by the
body to defend itself against bacterial, fungal, and viral infections[44]. Defensins, and multiple
other similar substances, are produced by secretory epithelial cells (Paneth cells) that are present
at the base of crypts in the intestinal lumen and secretion has been shown to be controlled by the
normal endogenous microbiome[30][45]. Vaishnava(2008) showed that in order for a host to
express full levels of antimicrobial compounds from the Paneth cells, the entire normal microbial
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community was necessary, with reduced levels of expression in organisms lacking microbial
phyla[47]. Looking at the same relationship from a different angle, other studies have shown that
administration of certain bacterial species on top of the already present normal microbiome can
even induce expression of anti-microbial substances from the GI tract cells[46, 47]. As mentioned
earlier, some anti-microbial compounds are secreted in an inactive form by the host, many
defensins are an example of this as they are secreted as prodefensins. These prodefensins aren't
able to confer any protective benefits to the host until they undergo proteolytic cleavage by the
enzyme matrilysin[30][48]. Using GF mice, Lopez-Boado(2000) was able to identify that one of the
major factors controlling production and secretion of the enzyme is the presence and
colonization of the GI tract by B. thetaiotaomicron bacteria, yet another member of the "good"
Bacteroidetes phyla, which were shown to induce enzyme expression by Paneth cells[48]. Not
only do the endogenous microbes play a critical role in causing the secretion of necessary
protective molecules by the body to protect itself against invading pathogens, but the lack of a
microbiome (or the lack of the proper microbiome composition) can severely hinder host
defenses by not activating protective compounds or not activating the production of supporting
molecules necessary for host defense.
The Microbe Diet
Food is something that people of all ages, genders, nationalities understand. Everyone has to eat,
and in most cases, everyone enjoys it. But not many take the time to appreciate all the complex
and interconnected processes that must occur in the body to absorb nutrients and convert the
ingested organic substrates into useful energy. Studies of biochemistry and other scientific
courses devote significant portions of time studying metabolic processes such as glycolysis, the
citric acid cycle, and oxidative phosphorylation, making it seem as though humans possess
incredible amounts of metabolic abilities. Without taking anything away from the complexity
and engineering of these internal processes, the metabolic capabilities of the human body are
actually quite pathetic without the microbiome. The genetic information that the microbiome
contains for metabolism is far greater and far more versatile than the information encoded in the
human genome[49]. As a result, a significant portion of metabolism and metabolic homeostasis is
under the control of the microbiome. The importance of the microbiome to metabolism is very
intuitive, though, since digestion and absorption occurs primarily in the area where the GI
microbiome resides. The significance of the microbes to the processes becomes even clearer
through the numerous studies that have shown that GF mice require a markedly increased caloric
intake on a daily basis compared to mice containing normal, unaltered microbiomes in order to
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maintain the same body weight[30]. So what exactly are these bacteria doing for the host? Well,
they are vital to proper metabolism by carrying out two main functions.
The first of the functions that the microbiome carries out for the host in terms of digestion is by
allowing the host to have access to calories that they would normally be unable to access without
the aid of the microbes. One mechanism in which microbes unlock otherwise indigestible
sources of nutrients is by metabolizing large portions of dietary fiber to short-chain fatty acids
and usable monosaccharides[50]. Not having bacteria present in the GI tract to metabolize the
fiber would cause humans to miss out on a major energy source, but it would promote the
production and accumulation of potentially toxic metabolic by-products by the body as a direct
consequence of saprophytism, the process of obtaining nourishment from dissolved decaying
organic matter, as shown by Vella(1999)[50, 51].
Along with giving access to new energy sources, the microbiome also plays a role in promoting
the efficient absorption of ingested nutrients. Not only have studies shown that the presence of
the endogenous microbiome helps promote and support the activity of lipoprotein lipase in
adipose tissue resulting in increased tissue fatty acid uptake, but administration of specific
bacterial strands from the normal microbiome into GF mice has significantly improved nutrient
absorption[52]. Administration of B. thetaiotaomicron to GF mice resulted in increased colipase
expression, an important cofactor used by pancreatic lipase, which led to increases in efficiency
of hydrolysis and absorption of ingested lipids[53]. Not only that, but an increased expression of
the Na+/glucose cotransporter was seen in the intestine following the microbe administration and
colonization of GF mice, also causing an increased glucose uptake by the organisms[53].
Without the presence of the microbiome, human hosts would miss out on enormous energy
stores stemming from the lack of genetic capability to metabolize many forms indigestible
oligosaccharides and polysaccharides. Additionally, the absorption of nutrients that the human
body is equipped to deal with would be greatly reduced due to the lack of assistance that is
normally provided by the microbiome. Proper nourishment and metabolism hinges on the
presence of the microbiome, the human diet is truly a microbe diet; without them, inefficient
digestion and malnourishment is inevitable.
Although this is nowhere near a full comprehensive outline of the benefits that the microbiome
confers to the human host, it should be quite clear as to why the microbes are allowed to remain
in the body after their initial colonization after birth. It's incredible to think of just how big of an
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impact bacterial communities, and even simple specific bacterial antigens, have on the proper
development and maturation of the immune system, a system which has the power to determine
the entire course of a person's life. Along with supporting host defense development, the
microbes even work to develop their own weapons against invading pathogens. Finally, many
vital life-processes that an organism must carry out to survive are heavily influenced by the
endogenous microbiome, which is best shown in the critical roles the microbial populations play
in metabolism.
It's not you... It's the microbes
It's obvious now that the microbiome plays a major role in development and homeostasis
maintenance. But the microbial populations playing such a major role in maintaining overall
health and wellbeing in humans exposes humans to a whole new danger. The massive roles that
the microbiome plays in various aspects of immune system development and control means that
a loss of regulation of the microbiome itself could prove disastrous for the functions and
processes that it regulates in the body.
As modern science has come to realize the importance of the microbiome to the everyday health
of a person, there has been a great deal of data that has been published comparing the
microbiomes of healthy and diseased individuals showing that microbial compositions greatly
vary between the two groups in numerous diseases. To date, over 25 different diseases and/or
syndromes have been associated with specific alterations in the microbiome[54]. The implicated
diseases range from obvious candidates such as obesity to seemingly unrelated neurological
diseases like multiple sclerosis. In the following sections, the major health implications of the
microbiome will be further explored in the context of a few diseases that have been shown to
have their roots in the endogenous microbes residing in people’s guts.
Fat Bacteria?
Based on the metabolic roles that the microbiome plays in the human body, it doesn’t come as
much of a surprise that one of the first diseases related to altered microbial compositions was
obesity. Initial tests sought to compare the microbes that were present in normal “lean” mice and
genetically obese mice by analyzing the 16s rRNA sequences in samples from the two
microbiomes. The results showed a strikingly clear difference between the two groups in regards
to the ratio of Bacteroidetes and Firmicutes (which make up well over 90% of the gut
microbiome) with a dramatic decrease of about 50% in Bacteroidetes and a major proportional
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increase in Firmicutes in obese mice when compared to lean mice[55]. Further studies using other
murine models for obesity and even human models found the persistence of the high Firmicutes
to Bacteroidetes ratio in organisms suffering from obesity[56].
The clear divide between the two groups suggested that the drastically skewed ratio must signify
some sort of molecular change in the obese mice, and Turnbaugh(2007) demonstrated the
molecular explanation by delving deeper into the genomic differences between the “lean”
microbiome and obesity-associated one. Compared to “lean”-microbiome containing mice, obese
mice showed a marked elevation in genes for enzymes involved in polysaccharide digestion,
suggesting the obese mice are simply ultra-efficient at squeezing out every last bit of energy
from ingested food[57]. Fecal analysis confirmed the theory by demonstrating a greatly reduced
amount of energy remaining in the feces of obese mice[57].
The final test for the obesity-associated microbiome came in the form of microbiome transplants
from obese mice to GF mice. After colonization of the gut of GF mice by microbiomes from
either obese or lean donors, it was found that the obese phenotype was transmissible, meaning
that the microbiome itself was, at least in part, directly responsible for the diseased phenotype[57,
58]

. GF mice receiving the “obese” microbiome showed a 60% increase in fat storage and

developed insulin-resistance after just 14 days compared to the GF mice receiving the “lean”
microbiome[54, 57]. When the colonized GF mice were fed an obesity-inducing diet, both groups
showed weight gain, but more impressively, the obesity-associated microbiome mice showed
increased weight gain compared to “lean” microbiome mice and the microbiomes of “lean” mice
actually began to shift to resemble the obesity-associated microbiome as obesity began to set
in[57][58]. When plain GF mice lacking a microbiome of any kind were fed the same obesityinducing diet, however, they failed to experience any significant weight gain and never presented
with an obese phenotype, giving further support for the microbiome-caused obesity condition[59].
Burning Gut
While microbes can’t literally set a person’s gut on fire, they can (and commonly do) cause the
painful set of conditions referred to as Inflammatory Bowel Diseases (IBD). The role of the
microbiome in IBD’s or more specifically in Crohn’s disease and ulcerative colitis, was
elucidated in much the same way as it was in obesity: by initially comparing the microbiome of
healthy individuals compared to those suffering from the disease. Three main common trends
have been reported by studies seeking to explain the role of the microbiome in IBD’s: IBD
patients have a decreased diversity and stability in their gut microbiomes, they have markedly
13

decreased amounts of microbes that commonly confer anti-inflammatory properties to the host,
and the microbiome functions in altered or defective ways in IBD patients when compared to
healthy individuals[54, 60].
Many studies have attributed the initial triggering of IBD to defective mucosal barriers that
allows for infection and colonization of portions of the gut by pathogenic bacteria like the
Proteobacterium Mycobacterium and Klebsiella or the Actinobacteria phyla member,
Campylobacter[61]. After invasion by the opportunistic pathogens, they begin to quickly
propagate and severely diminish microbial diversity in the microbiome by essentially kicking out
endogenous microbes and out-proliferating other microorganisms. Others have also reported
elevated levels and proportions of pathogenic E. coli strains tightly bound to apical intestinal
epithelium’s of Crohn’s disease patients[63]. IBD patients also showed greatly decreased amounts
of Faecalibacterium prausnitzii, a bacterium that has been shown to be associated with antiinflammatory functions in the body by reducing the secretion of proinflammatory cytokines
while increasing that of interleakin-10, a molecule that functions as a regulator of the immune
system that prevents hyperactive immune responses[63, 64]. While many relationships are still
being explored between the microbiome and IBD, there is already evidence of a causal
relationship similar to obesity as the dysbiosis seen in the microbiome and it’s subsequent loss of
immune regulation that occurs in IBD has been greatly reduced and improved in models of IBD
via administration and gut colonization by anti-inflammatory microbes like Faecalibacterium
prausnitzii[64].
Aging as a symptom?
While obesity and IBD are only two small examples of diseases that have been related to
microbiome dysregulation, they point to very important points regarding the microbiome and
health. While the environment influences and shapes the microbiome throughout life, especially
early in life, later on the microbiome is capable of directly influencing the host and its health; the
relationship is a two-way street, it’s bidirectional. This is shown by how various environmental
aspects can influence the composition of the microbiome, but more importantly by how specific
disease phenotypes can be transmitted to healthy organisms by simply transplanting and
colonizing the healthy organism’s gut with the disease-associated microbiomes.
What has been one of the most interesting findings in microbiome research has been the way an
individual’s age impacts the microbiome, which is bringing in results that make age look like a
negative symptom of a changing microbiome. What many researchers have found is that
14

microbial compositions are far from being considered static, they’re constantly changing and
adjusting after the initial colonization with extremely dramatic changes occurring during infancy
through adulthood[17]. When Agans(2011) sought to compare the gut microbiomes of adolescents
to adults, for example, his results showed clear age-related microbiome differences between the
(Figure 2)[21].

Figure 2: Principle component analysis of microarray data
collected by Agans(2011) comparing healthy preadolescent/adolescent children (kHLT) and healthy adult
(aHLT). The gut microbiomes were measured and
compared by detecting microbial 16s rRNA genes [21].

Comparing samples from healthy adults and children, they found that both groups had
microbiomes dominated by the two major phyla (Bacteroidetes/Firmicutes) as expected, but the
microbiome of young individuals had a statistically significant increased abundance of beneficial
Bacteroidetes bacteria and Bifdobacterium[21]. Other studies have reported similar differences in
microbial compositions between age while showing nearly-perfect correlations between the aged
microbiome compositions and poorer scores on frailty indices used to evaluate age-related
clinical signs of deterioration in mice[65]. Van Tongeren(2005) was even able to correlate
increases in frailty in older individuals with decreases in bacterial groups that were previously
discussed as playing important beneficial roles in host health such as Lactobacillus and F.
prausnitzii bacteria[66].
While many of the reported data sets have been reported as correlations, it’s impressive to see
such tight correlations between aging and specific compositional changes in the microbiome.
What’s more interesting to think about is how aging has been shown to bring about microbiome
changes that have been associated with disease and negative health effects, such as increases in
“harmful” Firmicutes in proportion to Bacteroidetes, decreases in microbial diversity, and
decreases in “beneficial” microbes associated with immune regulation and homeostatic
maintenance[66-68]
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The New Frontier: The Brain
Many of the discussed diseases and health impacts related to the microbiome make sense, the
conditions all have some sort of mechanistic and intuitive link to the gut area of the body. But
how could the gut microbiota possibly influence other peripheral systems in neurological
disorders? How does it influence the nervous system? While the link connecting the microbiome
and brain has long evaded researchers, recent findings are making breakthroughs is this new
frontier of microbiome research.
To date, reports have been maintain containing evidence that the microbiome and the metabolites
of its microbes play significant roles in influencing behavioral and brain processes such as stress
responses, emotion-driven behavior, and various biochemical pathways in the brain[69]. While
much of the evidence is still fairly new and not many causal relationships have been established,
spending some time to review the current preclinical evidence of the gut-brain relationship is
worthwhile due to the consistent trends found in reports and possible clinical implications of the
findings.
Using GF mice and microbiome transplantation, Sudo(2004) was able to show the microbiome
plays a clear role in adult stress-responsiveness by monitoring the hypothalamic-pituitary-adrenal
reaction to stress of GF mice to mice colonized by normal microbiomes. Not only were plasma
levels of stress-response molecules (such as ACTH and corticosterone) significantly elevated in
GF mice lacking microbiome compared to mice with normal microbiomes, but the GF mice
actually presented with decreased brain-derived neurotrophic factors in the cortex and
hippocampus[69, 70]. To follow up on the findings the research group administered “beneficial”
bacteria in the form of Bifdobacterium to some of the GF mice and compared them to GF mice
that were administered pathogenic E. coli finding that the GF mice receiving beneficial microbes
demonstrated a reversal of their previously elevated response to stress while mice receiving E.
coli presented with an even further elevated response to stress[70]. While rapid responsiveness to
stress is essential to survival, the exaggerated and prolonged stress molecule elevation in GF
mice is purely detrimental to the host’s health.
But stress responsiveness wasn’t the only area of the human psyche that has been implicated in
being impacted by the microbiome. Many other reports have shown that a link exists between the
microbiome and depression, anxiety-linked behavior, learning and memory, and even social
behavior[69, 71, 82]. Pathogenic bacteria and high proportions of Firmicutes have been linked to
increased emotional behavior, increased incidences of anxiety-like phenotypes, impaired
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learning and memory functions, and reduced social interactions and ASD-like behaviors[81-86].
Phenotypes such as depression and anxiety have been reversed through the use of probiotics
containing “beneficial” and normal microbial populations, seeking to push hosts’ microbiomes
towards compositions that are normal84, 86]. A fascinating find has been made using ASD model
mice, however, use of probiotics containing Bacteroides fragilis to behavioral and social
improvements in mice[87].
Other intriguing evidence has emerged from research looking at these specific phenotypes, with
multiple studies linking the effects of diet on the microbiome to the depressed phenotype[72].
Meta-analyses suggested that healthy diets (more specifically Mediterranean-style diets) and the
beneficial effects on the microbiomes, markedly reduce the incidence of depression in
individuals and seem to confer protection against cognitive decline when compared to diets rich
in sugars and fat, which are tightly correlated to increased psychological symptomology[73]. But
while these results are impressive to see, are there truly any causal relationships between the
microbiome and the depressed and anxious phenotypes? Or is it just a coincidence? Studies led
by Bested(2013) and others sought to solve this question by seeing if psychological phenotypes,
like other disease phenotypes, could be transmitted via microbiome transplantation and the
results were nothing short of stunning, showing that not only could the anxious phenotype be
transferred via gut microbiome transplantation, but manipulation of the gut microbes via
probiotics and antibiotics can alter and reverse depressed phenotypes[74-76].
So if these psychological phenotypes can be transferred by the microbiome then what is really
going on a molecular level, what specific microbes are responsible? As it turns out, all the
microbial populations that have been previously discussed as part of the normal healthy
microbiome and those as part of the pathogenic, disease-causing group retain their respective
roles when influencing the nervous system.
Many of the microbes that have been described as harmful, especially elevated proportions of
Firmicutes to Bacteroidetes, commonly compromise the tight junctions that are meant to form an
epithelial barrier to the outside environment[77]. This disruption, commonly referred to as “leaky
gut,” is caused by lack of proper host-microbiome interactions that have been previously
discussed as vital to immune development and the lack of needed beneficial microbes to confer
protective benefits against invading pathogens. When the intestinal defenses are compromised,
bacteria-derived lipopolysaccharides (LPS) can access to system circulation and levels rise
throughout the body triggering immune and inflammatory responses that can be tracked by rising
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levels of pro-inflammatory cytokines throughout the body[78]. This sort of inflammation has been
implicated as one of the causative factors of depressive symptoms, as demonstrated by studies
that have found high levels of immunoglobulins against bacterial LPS circulating in the plasma
in patients suffering from chronic depression[79]. In animal models researchers have even been
able to induce the depressed phenotype by prolonged administration of LPS, which can be
reversed through administration of anti-depressants[79]. Along with sending molecules into
circulation, those suffering from leaky gut are also prone to experiencing microbial translocation
across epithelial boundaries that would normally be impermeable to bacteria, which has been
shown to trigger autoimmune responses by immune systems that target intestinal serotonin and
its receptors, culminating in increased feelings of fatigue and illness behavior in patients[80].
Another impressive recent development in the search for the link between the gut and the brain
has been the work of Brainiste(2014) which has shown that the lack of the normal endogenous
microbiome actually functions to increase permeability of the blood-brain barrier, thereby giving
potentially harmful metabolites of immune responses and pathogenic microbes access to the
brain itself[82]. There have even been links made between brain development and the microbiome
such as GF mouse models displaying decreased brain-derived neurotrophic factor in the
hippocampus, altered expression of GABA A and B subunits, and altered expression of NMDA
receptor subunits[88, 90]. Other studies have found that abnormal microbial compositions can
actually decrease the abundance of proteins needed for proper brain development such as PSD95 and synaptophsin in the brain[90].
While this discussion won’t be able to give a full explanation and run-down of the discussed
studies and the exact molecular mechanisms responsible for the microbiome induced effects on
the brain one point should be clear: they definitely exist. While many precise causal relationships
are still yet to be found, the tight correlations are starting to show the growing importance of the
microbiome to all aspects of health. Not only are the microbes affecting systems in the gut, but
abnormal and pathogenic microbes can, and do, have very negative effects on peripheral systems
throughout the body, going as far as the brain to affect the host’s psyche and neural development.

The microbiome and its effects on the human body are both varied and complex. But it cannot be
denied that a relationship between the two exists. Not only does it play a vital role in
development throughout life, it can ultimately affect the host’s health and wellbeing. While
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many are often quick to write-off studies relating the microbiome to various diseases, modern
scientific literature shows that it’s undeniable that the endogenous commensals are involved on
some level in nearly all human diseases. This basic belief was what prompted the study that will
be discussed in later sections.
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Introduction
Each year, nearly 800,000 individuals residing in the United States will have a stroke. Of these,
about 130,000 cases will prove fatal while many of the survivors will be forced to live with
disability for the remainder of their lives. Out of all strokes over 87% are ischemic strokes. An
ischemic stroke, in the most basic sense, is the initiation of the ischemic cascade in response to a
loss of blood supply to a part of the brain. The lack of oxygen due to a lack of blood to neurons
severely hinder the cells' abilities to synthesize ATP through normal processes which forces cells
to switch to anaerobic metabolism. While anaerobic metabolism can generate sufficient levels of
ATP for basal levels of survival for very brief periods of time, it is in no way prepared to sustain
cellular life for the time frames that are involved in strokes, which can last from minutes to
several hours. This energy failure will ultimately result in the slowing and failure of ATPdependent ion pumps in neurons that are absolutely vital for survival. Pump failure will lead to
cell depolarization and excess neurotransmitter release. At the cellular level, this cascade will
culminate in the production of harmful free radicals, reactive oxygen species, and the over
activation and production of ion-dependent enzymes resulting in the breakdown of the cell's
components and cell death. If, or when, the brain is re-perfused, the tissue will experience further
injury on the macro scale due to a sweeping inflammatory response to cell damage, damage to
the blood-brain barrier, and rampant edema. The widespread incidence of this debilitating
condition costs the United States an estimated $36.5 billion dollars every single year. Despite
this, clinicians are armed with very little to combat the disease.
Recent research developments have brought about the rise in awareness about the importance of
the microbiome, the various gut flora present in all organisms, in relation to disease prevention,
management, and treatment. Many of the risk factors for stroke including high blood pressure,
obesity, and diabetes have been found to be not only affected by the microbiome, but can also be
changed, altered, and even reversed by changing the microbiome itself. Alterations in microbial
diversity can increase the risk of many diseases ranging from obesity to multiple sclerosis to
aging, but changes in the microbiome after ischemic stroke have not yet been examined. In
addition, it is unknown if changes in the microbiome can influence either stroke severity or
stroke recovery. This paper will seek to find the answer to these questions.
This paper will demonstrate the success of microbiome transplantation between recipient and
donor mice, will explore the trends seen in the composition of the microbiome after stroke, and
will seek to find a link between the microbiome and stroke outcomes. Being able to successfully
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and selectively alter the microbiome in an organism to reduce the harmful effects of stroke and
improve recovery would not only be a completely novel potential direction in stroke research,
but could offer a plethora of innovative treatment options that could be readily implemented
through techniques already used for the treatment of Clostridium dificile infection or through
simple probiotic formulas. This study’s findings could lead to invaluable insights into the
relationship between the gut, the immune system and the brain and may be able to identify new
targets to enhance functional recovery after stroke.

Purpose
This project sought to examine the effect of the microbiome on stroke outcomes after
experimental stroke in mice. Initial experiments were conducted to confirm reports that marked
changes can be observed in the microbiota with age and results demonstrated that marked
differences occur in the microbiome of young vs. aged mice. It is now widely recognized that
that as organisms’ age, there is a corresponding increase in circulating inflammatory markers.
This pro-inflammatory milieu makes organisms less able to cope with a variety of stressors,
including stroke. Aged animals (and humans) have increased mortality and poorer recovery after
ischemic stroke compared to their young counterparts. Clear differences in the ratio of the two
major phyla of microbes present in murine microbiomes (Bacteroidetes/Firmicutes) in young vs.
aged mice were observed, with aged mice presenting microbiome compositions associated with
harmful health effects. Young animals have a high ratio of Bacteroidetes to Firmicutes while
aged animals have the opposite. A similar relationship has also been seen in the human
microbiome. Additionally, it was found that after an experimental stroke the microbiome
composition of young animals’ changes to resemble the composition of that seen in aged nonstroke mice. These findings could prove to be of substantial value to stroke research since it has
already been confirmed by many other studies that high relative abundances of Firmicutes to
Bacteroidetes (ratios resembling aged animal microbiomes) are tightly correlated to
hypertension, cardiovascular complications, and obesity; all of which are direct risk factors that
can both increase the incidence of ischemic stroke as well as dramatically reduce recovery after
an ischemic event[50-56, 91, 92].
The goal of these experiments was to examine the effect of transferring a young microbiome into
an aged animal, to determine if restoring a more “youthful” microbiome will reduce morbidity
and mortality after stroke. I hypothesized that transplantation of theoretically beneficial
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microbiome from young mice into aged mice can improve functional recovery in aged recipients
post-stroke when compared to aged mice that receive aged donor transplants. Using the same
logic, a group of young mice received aged fecal transplants, which I hypothesized would
experience worsened stroke outcomes when compared to the young controls.

Materials/Methods
Mice
The experiment used a total of 48 male mice. 24 young mice housed at the laboratory following
birth and were a housed two mice per cage for a period of two months prior to any experimental
procedures for habituation purposes. 24 aged mice born 4/2013 ordered from The Jackson
Laboratory were also used in the experiment and were also held in the lab for a 2-month
habituation period after arrival. At time of the procedure young adult mice were approximately
two months of age (considered to be equivalent to 18 year old humans) while aged mice were 16
months of age making them equivalents to 55-60 year old humans. Mice were housed in standard
mouse cages with suspended wire mesh bottoms to prevent cacophagy. This study was
conducted in accordance with the National Institute of Health guidelines for the care and use of
animals in research and under protocols approved by the Center for Lab Animal Care at the
University of Connecticut Health Center.
Fecal Transplantation
3 aged mice and 3 young mice were chosen as donor mice who’s feces would be used for
microbiome transplants into recipient mice. Fecal pellets from the donor mice were collected and
placed in 1.0mL of iced phosphate buffered saline solution (PBS). Final volumes were adjusted
to ensure a concentration of 120 mg donor feces per mL PBS. Sterile wooden toothpicks were
used to mash fecal pellets in the PBS until a paste-like consistency was reached followed by
vortexing the solution at maximum speed for a total of 1 minute. The solutions were then
centrifuged at 800 × g for 3 minutes. The supernatant from the centrifuged solution was then
removed and used for the transplants into the recipient mice. Protocol was similar to those
described in previous studies[94, 95].
Endogenous gut microbiomes of the recipient mice were suppressed as much as possible prior to
transplantation via administration of 2 concentrated antibiotic doses. Streptomycin HCl
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suspended in sterile water at a concentration of 500 mg per mL was used. Each mouse received
50 µL per dose administered directly into their oral cavities. 24 hours following the initial
antibiotic dose, the mice received a second dose of the antibiotic to attempt to suppress
endogenous microbial populations as much as possible.
Fecal transplants of the supernatants collected from donor feces were administered to recipient
mice at 24 and 48 hours following the second antibiotic dose. (Figure 3)
Pre-train
for Open
Field/Hang
wire prior
to stroke
Habituation, n=48
-young mice housed at
UCHC since 7/2014
-aged mice DOB
4/2013

1 month, n=48
-2 doses concentrated
streptomycin HCl suspended
in sterile H2O (500mg/mL)
-fecal transplants given 24
and 48 hours after second
dose of antibiotic

60 minute MCAO 1 month post
fecal transplant

D1 Post- D3 Post- D7 Poststroke: Stroke:
Stroke:
-NDS
-NDS
-NDS
-Open Field -Open Field
-Hang Wire -Hang Wire

2 wk PostStroke:
-NDS
-Open Field
-Hang Wire

3 wk PostStroke:
-NDS
-Open Field
-Hang Wire

Figure 3: Experimental design. Young and aged mice were both held unaltered for a 2 month habituation
period prior to any experimentation (green section of timeline). After habituation, antibiotics and fecal
transplants were administered to mice as described. Following transplantation, mice were held in cages for
1 month to allow for newly transplanted microbiomes to colonize and stabilize in the gut of the recipient
animals (orange section). At the end of the 1 month post-transplant, mice were pre-trained on behavioral
tests and at exactly 1 month post-transplant, stroke mice were given experimental 60 minute middle
cerebral artery occlusions and sham mice were given sham surgeries. Mice were scored for neurological
deficit at days 1, 3, 7, 14, and 21 post-stroke and were tested via hang wire and open field behavioral tests
at days 3, 7, 14, and 21. At 3 weeks post-stroke, mice were sacrificed using a 2% Avertin solution at a dose
of 0.1mL/10g body weight and perfused with heparinized PBS, followed by 4% paraformaldehyde. Once
fixed, the brain tissue will be harvested, placed in 30% sucrose until dehydrated. The brains will be
sectioned into 30μm-thick slices on a microtome and the sections will then be stained using cresyl violet to
measure and analyze infarct size to compare tissue damage.

Fecal Collection
Fecal samples from mice were collected both prior to experimental procedures and following
transplantation. To collect samples, mice were removed from cages and individually placed on
sterile surfaces until they defecated. Stool samples were then collected and placed in sterile tubes
to be stored at -80° Celsius. Sterile protocol was followed during collection. 70% ethanol was
used on all surfaces prior to collection and in between mice during stool collections. Gloves were
changed between each mouse to avoid all potential sources of cross-contamination of samples.
Experimental Stroke
Focal transient cerebral ischemia was induced in the experimental mice via a 60 minute
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reversible right middle cerebral artery occlusion under isoflurane anesthesia followed by
reperfusion as previously described[93]. Silicon coated sutures, 0.21 and 0.23 mm in dimension,
were used to occlude the middle cerebral arteries of young and aged animals, respectively.
Throughout the surgery and ischemia mouse rectal muscle temperature was measured and
monitored using a Monotherm system maintaining body temperature at 37 degrees Celsius via an
automated feedback mechanism. Sham mice underwent the same procedure except sutures were
not advanced into the middle cerebral arteries for occlusion. The model provided for a consistent
model of ischemia in the murine brain that was uniform throughout the cohort. Following
ischemic stroke, all animals were given 0.2 mL saline injections subcutaneously for the first
week following the procedure along with free access to wet mashed food to ensure survival
Behavioral Testing
Prior to all behavioral testing, all mice were acclimated for 1 hour in the testing rooms in their
home cages. Sterile protocol was followed with the testing rooms and equipment. All equipment
was cleaned with 70% ethanol in between trials and in between mice. Tests were conducted at
the same time of day each time they were administered for consistency. Animals were pretrained on all tests prior to stroke to assess baseline scores for all the mice.
Neurological Deficit Scoring
Neurological deficit scores (NDS) were collected before and after stroke. Score was taken
immediately following stroke at reperfusion, 1 day post-stroke, and at days 3, 7, 14, and 21 poststroke as shown in the experimental design in Figure 3. The score is determined using a 5-point
scale: 0, no deficit; 1, forelimb weakness and torso turning to the ipsilateral side when held by
tail; 2, circling to affected side; 3, unable to bear weight on affected side; 4, no spontaneous
locomotor activity or barrel rolling.
Open Field Test
The open field test is administered to mice to assess general locomotor activity. The starting
placement of each mouse's trial was in the front right corner of a clear, acrylic box (16 inches by
16 inches). Once placed in the starting spot, each mouse was allotted a 10 minute interval, during
which it was completely free to roam and explore the enclosed area. Activity was quantified
using a computer operated PAS open field system computer program (San Diego Instruments,
San Diego, CA). Locomotor activity was measured as the total number of laser beam breaks
within the area as the mouse moved about. The test was administered to the mice prior to stroke
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to assess basal levels of movement and then at days 3, 7, 14, and 21 post-stroke.
Hang Wire Test
The hang wire test assesses the sensorimotor functions in mice. A wire cage top of dimensions
18 inches by 9 inches was used for the procedure. Mice were placed on top of the cage in the
center, andd the wire lid was then slowly inverted and placed at a height of 9 inches above an
empty cage bottom containing regular bedding. The time between inversion to the moment the
mouse fell from the inverted cage was measured. A total of three trials was used per mouse, with
a 45 minute gap in between each trial. The average of the three trials was then compared to the
latency to fall measured at baseline for each mouse.
Cresyl Violet Staining
After sacrifice, brains of each mouse were harvested, placed in 30% sucrose until dehydrated.
The brains will be sectioned into 30
30µm-thick
thick slices on a microtome and the sections will then be
stained using cresyl violet to measure and analyze infarct size to compare tissue damage.
Statistics
All values are expressed as mean±SEM and analyze
analyzed with a t-test
test for two groups.
groups All
assessments were performed
ormed by a blinded investigator. The criterion for statistical significance
was P<0.05.
Results
Aged vs. Young Microbiome Compari
Comparison
Fecal Sample Composition Broke Down by Microbial Phyla
100%
p__Proteobacteria

90%
80%

k__Bacteria

70%

p__Tenericutes

60%

p__Cyanobacteria

50%

p__Deferribacteres

40%

p__Actinobacteria

30%

p__Verrucomicrobia

20%

p__Firmicutes

10%

p__Bacteroidetes

0%
Young donor

Aged donor

Figure 4: Sequencing data from
samples collected from Aged and
Young mice. Breakdown of fecal
sample composition at the phylum
level. Samples collected prior to any
experimental treatment during
habituation periods to assess basal
levels of microbial compositions
compo
between the groups of mice.
Data confirmed previous reports
stating that >90% of the gut
microbiome is composed of
Firmicutes and Bacteroidetes phyla.
Trends of an increasing Firmicutes
to Bacteroidetes ratio was also seen
with increasing age as previously
reported by other studies.
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Prior to any experimental procedures, fecal samples were collected from aged donor mice and
young donor mice for purposes of confirming previous reports on microbial compositions.
Sequencing data confirmed reports of gut microbiomes being >90% composed of two phyla
(Bacteroidetes/Firmicutes). As shown in Figure 4, young microbiome samples displayed high
Bacteroidetes/Firmicutes ratios, with Bacteroidetes(in blue) composing roughly 65% of the
microbiome on average. Aged mice, demonstrated the opposite ratio with much greater
abundances of Firmicutes(in red). Interestingly enough, young samples contained larger portions
of Verrucomicrobia within their microbiomes, with the phyla varying in abundances between 89% in the animals while the phyla was virtually unseen in aged samples at abundances of nearly
zero in most animals while the aged animals showing the highest abundances never contained
more than 4% of the phyla. Many of the aged animals also contained a presence of
Deferribacteres while nearly all young samples contained no detectable presence of the phyla.
Microbiome Transplants
Aged Mice

Stroke

Sham

Young fecal transplant

n=8

n=4

Aged fecal transplant (control)

n=8

n=4

total

n=16

n=8

Young Mice
Young fecal transplant (control)

n=8

n=4

Aged fecal transplant

n=8

n=4

total

n=16

n=8

32 strokes

16 shams

4 Types of Fecal Transplants carried out:
1. Young donorYoung recipients (control)
2. Young donorAged recipient
3. Aged donorAged recipient (control)
4. Aged donorYoung recipient
Table 2: (on left) the breakdown of the basic groups used
in experimental design. A total of 8 separate groups were
used to give a total n of 48 mice. Different transplant
groups were divided into stroke and sham groups, sham
surgeries as controls. (on right) the 4 types of microbiome
transplants that were used in the experimental design. 2
controls groups were used to control for antibiotic
treatment and the transplant procedures themselves.

Total
n=48 mice (24 young/24 aged)

The experimental procedure required various control groups to control for antibiotics, the
transplant procedures, and then stroke surgeries. As shown by Table 2, the aged and young mice
were broken down into 4 main transplant groups: 1, young mice receiving young microbiomes;
2, young mice receiving aged microbiomes; 3, aged mice receiving aged microbiomes; 4, aged
mice receiving young microbiomes. The aged and young mice that received microbiome
transplants from their own respective age group were the control groups for any differences that
could have arisen from the antibiotics or transplant procedures themselves. The 4 main transplant
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groups were then further broken down into mice that would receive stroke surgeries and mice
that would only receive sham surgeries
urgeries to control for the surgical procedure.

Figure 5: (on left) on top is the sequencing data of fecal samples from donor mice that were used, as shown on a
larger scale in Figure 4. Below is the sequencing data of fecal samples collected from young and aged reciepient
mice that received microbiomes from their own respective age group. (on right) donor data depicted on top for
comparison purposes again, below is sequencing data of fecal samples from young mice receiving aged microbiome
transplants and aged mice receiving young microbiome transplants. In all cases, successful microbiome
transplantation could be seen in clear transmission of the Bacteroidetes/Firmicutes ratio from donor mice to
recipients 1 month following transplant.

Figure 5 depicts sequencing data at a phylum level of fecal samples ccollected
ollected from young and
aged recipient mice 1 month after microbiome transplantation. Young controls showed
successful transplantation from young donor mice, showing clear similarities in microbial
composition to donors as well as successful transmission oof high the high
Bacteroidetes/Firmicutes ratio. Aged mouse controls showed the same results except with the
opposite microbial ratio, displaying low Bacteroidetes/Firmicutes ratios as would be expected in
aged microbial populations. Sequencing data of feca
fecall samples from successful young and aged
recipient mice 1 month following transplantation showed successful transmission of the
Bacteroidetes/Firmicutes ratio of interest from donors to recipients.
Sequencing data of fecal samples taken from Young mice th
that
at underwent successful fecal
transplants from Aged mice showed a reversal of the Bacteroidetes/Firmicutes ratio, resembling
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the low ratio that was commonly seen in Aged mice. An elevated proportion of the
Deferribacteres phyla could also be observed that was greater than in any young controls and
donors. Data from fecal samples taken from Aged mice than underwent successful transplants
from Young mice also showed a common trend of reversal in the Bacteroidetes/Firmicutes ratio.
The resulting high ratio resembled that of young donors and greatly exceeded any of the ratios
seen in Aged donors/controls. An extraordinary elevation in the Verrucomicrobia phyla was also
commonly seen in the Aged mice receiving young fecal transp
transplants
lants but not in any of the aged
controls/donors (Figure 6).
0.9
0.8
0.7
0.6
0.5
0.4

Bacteroidetes

0.3

Firmicutes

0.2
0.1
0
Aged w/ Aged
Transplant

Young w/ Aged
Transplant

Aged w/ Young
Transplant

Young w/ Young
Transplant

Figure 6: Relative abundances of Bacteroidetes/Firmicutes in mice following fecal transplantation. Marked
elevation of Bacteroidetes in mice receiving young microbiomes while the opposite is ttrue
rue in mice receiving aged
microbiome transplant. Previously reported aged dependent ratios of Bacteroidetes/Firmicutes microbes were
observed in mice receiving transplants.
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Figure 7a: Neurological deficit
scores of young mice post-stroke.
post
Prior to reperfusion all animals
scored 0 on the NDS scale,
indicating no basal levels of
neurological deficit.
Following stroke, significantly
improved recovery was seen in
young mice with gut microbiomes
of young donors recovering after
3 weeks. Young mice that
received the microbiomes of aged
donors demonstrated markedly
reduced recovery and never fully
returned to basal levels of no
neurological deficit.
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4.00
3.50
Neurological Deficit Score

Figure 7b: Neurological deficit scores
of aged mice obtained following
stroke. All animals had basal scores of
0 prior to stroke indicating no
neurological deficit prior to ischemia.
No significant differences between
aged mice receiving aged and young
microbiomes
crobiomes were observed.
No full recovery was seen at 3 weeks
as it was with young mice, however.
The final overall trend of recovery
suggested full functional recovery of
aged mice that received young
microbiomes while aged mice
containing aged microbiomes
microbiom
appeared to be trending to never fully
functionally recover.

Aged mice

3.00
Young
Transplant
Aged
Transplant

2.50
2.00
1.50
1.00
0.50
0.00
at
reperfusion

D1

D3

D7
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Microbiome composition seemed to have a significant impact on recovery from neurological
deficit in young mice (Figure 7a). Young mice that received young microbiota had markedly
improved recovery
overy times after stroke according to their NDS scores compared to the mice that
received aged transplants. The mice that received young microbial compositions also
demonstrated full functional recovery at 3 weeks whereas the animals that contained aged
microbiome
crobiome never fully recovered from ischemia.
A significant difference in functional recovery wasn’t seen in aged mice regardless of
microbiome composition (Figure 7b
7b). 1 week post-stroke,
stroke, however, a difference in trends began
to form as aged mice containing aged microbiomes seemed to be on track to fully recover while
recipients of aged microbiota appeared to plateau in their recovery suggesting a lack of full
functional
nal recovery. The study would need to be repeated, however, with increased survival
times prior to sacrifice to confirm this observation.
Hang Wire Test
Hangwire Test Aged Stroke Mice

Time (seconds)

70
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Young Transplant
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Aged Transplants
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Figure 8a: Latency to fall
during hang wire test for
aged mice post-stroke.
post
Mice tested pre-stroke
pre
then 3, 7, 14, and 21
days after stroke. Aged
mice that received young
microbiome transplants
outperformed the aged
mice that received
microbiome transplants
from aged donors.
Differences in
performance were
dramatically amplified
by stroke.
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Figure 8b:Latency to fall
during the hang wire test for
aged mice that received
sham surgeries instead of
middle cerebral artery
occlusions. Mice with young
microbiomes outperformed
those with aged microbiomes
but at 3 weeks post-surgery
post
the differences were roughly
the same
sa as they were prior
to surgery.
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Figures 8a and 8b depict the data collected from aged mice that underwent stroke surgery
(Figure 8a) and those that underwent sham surgery (Figure 8b). In both groups, aged mice
that received young microbiome transplants performed better on the hang wire test as
depicted by their increased latencies to fall. Aged mice that received transplants from
young donors had improved performances on the hang wire test as compared to those that
received transplants from aged donors aat basal levels during pre-training
training and the
differences were found to be further amplified following stroke when measured at 3 weeks
whereas the differences in performance stayed relatively stable in sham surgery mice.
Hangwire Test Young Stroke Mice

Figure 9a: Latency to fall
during hang wire test for
young mice that
underwent ischemic stroke.
Mice with young
microbiomes outperformed
those with aged
microbiomes. Stoke
appeared to amplify the
differences at 2 weeks post
stroke but the two groups
were closer in performance
by 3 weeks post-stroke.
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Figure 9b: Latency to fall
on the hang wire test
following sham surgeries.
Similar differences in
performance as in other
groups, young
microbiomes
outperforming aged.
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Trends noticed in aged animals were also seen in young mice except on a reduced scale. Young
animals that received microbiota of aged animals had a markedly decreased latency to fall as
compared to mice that received transplants from young donors during initial phases of recovery
as seen by the marked differences in fall la
latency at weeks 1 and 2 post-stroke.
stroke. At 3 weeks postpost
stroke, however, all young animals had nearly the same performance on the hang wire test,
mirroring the recovery of young mice as seen in the NDS data.
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Figure 11: Latency to fall on the hang wire test of young and aged mice at pre
pre-training pre-stroke
stroke and 2 weeks postpost
stroke. Pre-stroke
stroke young mice outperformed aged mice, however the young mice that were the recipients of
microbiome transplants from young donors
onors outperformed young mice that received transplants from aged donors.
A similar trend within the aged mice was seen with the young microbiome recipients outperformed aged
microbiome recipients. At 2 weeks post
post-stroke, the differences within age groups were significantly amplified.
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Open Field Test/CV Analysis

Percent decrease in mobility following stroke
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Young with Aged Fecal Transplant
80
Young with Young Fecal Transplant
60
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40

Aged with Young Fecal Transplant

20

0
3 Days Post-Stroke
Stroke
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-20

Figure 12: Open field data collected from mice following stroke. No significant differences were found between any
of the groups during trials. As shown in the figure, large variation was seen in the cohort and no clear trends were
observed.

Young

Aged

Figure 13: Cresyl violet staining of harvested mouse
brains 3 weeks post-stroke.
stroke. Infarct volume did not
appear to be dependent on microbiome
composition. Infarct volume of young mice was
significantly larger than that of aged mice, as has
been reported in the literature.

No significance was found in the results of the open field test or during CV staining/analysis of
the harvested brains following stroke. Perhaps a larger n is required to see trends or perhaps the
microbiome has no impactt on infarct volume. Open field test would need to be repeated again
with a larger n since the results seem to contradict the collected data from the hang wire tests and
NDS.
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Discussion
The experimental results clearly showed encouraging trends linking the microbiome to
functional recovery following ischemic stroke. As it has been reported in the literature,
microbiome samples collected via the feces confirmed the phylum-level differences between
aged and young organisms. Young microbiomes seem to contain a high Bacteroidetes/Firmicutes
ratio while the opposite is true for aged mice(Figure 6). The low ratio, as present in aged
animals, has been linked to various risk factors for stroke and diseased conditions in the
literature, which formed the basis of the hypothesis that this “harmful” population of microbes
could potentially hinder functional recovery in young animals following stroke while giving then
“beneficial” microbiome of young animals to aged animals could help positively impact
functional recovery following stroke[8-17].
The NDS and hang wire test results helped support this hypothesis by suggesting the young
microbiome can protective or encouraging of functional recovery in both young and aged
animals. Both young and aged mice that received aged microbiome transplants demonstrated
decreased recovery based on the NDS and hang wire test results. The differences in the animals
were present pre-stroke, but were dramatically amplified and obvious following ischemia,
suggesting that perhaps the aging microbiome doesn’t play a major role until some sort of
stressor is present, at which point young microbiomes can confer protective benefits while the
aged microbiome lacks the capacity to do so.
The low Bacteroidetes/Firmicutes ratio has been linked to increased circulation of inflammatory
markers, cardiovascular risk, tendency for obesity; all risk factors for stroke[30-68, 91, 92]. This has
proven harmful to multiple inflammatory diseases, so it is not much of a stretch to expect the
ratio to have a negative impact on a cardiovascular disease like ischemic stroke. Stroke has been
also linked to cause an increase in gut permeability, and “leaky gut” syndrome has commonly
been linked to disease and harmful effects on host health following gut microbe translocation and
the transmission of microbe metabolic products into systemic circulation[77-80]. The combination
of leaky gut post-stroke and harmful metabolic products resulting from the relatively high
Firmicute abundance in the aged microbiome could be the explanation for worsened recovery in
animals containing the aged microbiome post-stroke. It could also help explain the reason for the
nearly non-existent differences between groups prior to stroke, whereas following ischemia there
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are dramatic behavioral differences. This could also explain why animals containing a high
Bacteroidetes/Firmicutes ratio seem to be more protected from stroke and demonstrated
improved recovery since they have been reported to confer protective benefits to the host and
promote up-regulation for proteins in tight endothelial junction (which could help protect from
leaky gut or blood-brain barrier breaches), promote improved responses to stress in terms of a
less overactive stress response, and help prevent large inflammatory responses by the innate
immune system[50-56, 70, 90-92] .
It was disappointing to not observe any of the same trends in the open field test. Unfortunately,
no significant results were collected from the test, which failed to further support the hypothesis
of the young microbiome being conducive of functional recovery post-stroke while the aged
microbiome is harmful. Aged and young organisms are known to have different infarct volumes
following ischemic attack. While young animals typically experience greatly improved
functional recovery after stroke than their aged counterparts, the young mice typically have much
larger infarct volumes in their brains. CV staining and analysis did not demonstrate any positive
or negative impacts of microbiome composition in the experimental mice.
While these results are very promising and inspiring, since the trends are very clear in the NDS
and hang wire results and are theoretically supported by the literature, much more work will need
to be done in the future to elucidate the exact link between the microbiome and ischemic stroke.
While the n of 48 was a fairly large number, there was still a fair amount of variation observed in
the data so the n will have to be greatly increased and further tests will need to be conducted. The
open field test should be repeated on a larger scale to find trends that could potentially exist that
were overlooked. A longer survival time of 4-6 weeks should be used for following cohorts to
allow for a greater window of time to see the development of the trends that were seen during
these experiments. While the tests that were used with this cohort gave glimpses into the motor
impacts of the microbiome on stroke recovery, it would be interesting to expand the pool of
behavioral tests to more cognitive-based tests such as the novel object recognition test which
tests the learning and memory or elevated maze tests that test the animals for anxiety. All these
thoughts will be put into consideration for future experimentation to create a full test of the
microbiome’s impact on an organisms motor and cognitive recovery following ischemic stroke.
The results reported here, though, give invaluable insight into this novel area of research offering
support that the microbiome does, in fact, play some role in functional recovery of mice.
Using the data reported here, the hope will be to see similar trends in future data. If successful,
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these results could truly prove to be monumental, offering totally new potential avenues for
stroke treatment and prevention.
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